Indegene Limited (INDGN)
Outcome of Board Meeting
Q2FY27 results (unaudited):
Standalone:
Revenue 3.7bn +20% y-y (3.1bn)
PAT 0.6bn +7% y-y (0.57bn)
Consolidated:
Revenue 21.9bn +40% y-y (15.7bn)
EBITDA 4.0bn +38% y-y (2.9bn)
EBITDA margin 18.3% (18.5%) -20 bps y-y
PAT 2.3bn +5% y-y (2.2bn)
H1FY27 results (unaudited):
Standalone:
Revenue 7.1bn +26% y-y (5.6bn)
PAT 1.2bn +7% y-y (1.1bn)
Consolidated:
Revenue 22.3bn +39% y-y (16.1bn)
EBITDA 7.4bn +38% y-y (5.4bn)
EBITDA margin 18.1% (18.0%) +10 bps y-y
PAT 2.3bn +5% y-y (2.2bn)
FY26 results (audited):
Standalone:
Revenue 12.2bn +30% y-y (9.4bn)
PAT 2.1bn +18% y-y (1.8bn)
Consolidated:
Revenue 35.1bn +20% y-y (29.3bn)
EBITDA 6.6bn +9% y-y (6.0bn)
EBITDA margin 18.8% (20.5%) -170 bps y-y
PAT 4.0bn +9% y-y (3.7bn)
Dividend: 2.25 per share (paid on 21 August 2026)
Commentary: The FY26 results include an exceptional litigation expense of 0.2bn related to a US class action settlement.
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 INDGN — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add INDGN to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Indegene Limited
Important.
The summary above is generated automatically from Indegene Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.